Neurent Medical Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Later Stage VC
- Investors
-
7
Neurent Medical General Information
Description
Developer of non-surgical intervention device designed to treat chronic rhinitis safely. The company specializes in minimally invasive hand-held radio-frequency devices that are introduced through the nostrils into the nasal cavity under direct endoscopic visualization where it deploys a microelectrode array that delivers targeted energy to interrupt the autonomic function within the mucosal structures of nasal cavities which will reverse the inflammatory cascade, enabling surgeons to treat patients in an office setting, removing the complications and costs associated with most surgical procedures.
Contact Information
Website
www.neurentmedical.comCorporate Office
- 150 Grossman Drive
- Suite 203
- Braintree, MA 02184
- United States
Corporate Office
- 150 Grossman Drive
- Suite 203
- Braintree, MA 02184
- United States
Neurent Medical Timeline
Neurent Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 15-Jun-2022 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 30-May-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 20-Jan-2021 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 07-May-2020 | Completed | Generating Revenue | |||
| 2. Grant | 10-Dec-2018 | $3.18M | $5.5M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 16-Jul-2018 | $5.5M | $5.5M | Completed | Generating Revenue |
Neurent Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A Preference | ||||||||
| Series A Preference | 123,547 | $0.001089 | $40.96 | $40.96 | 1x | $40.96 | 22.75% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Neurent Medical Comparisons
Industry
Financing
Details
Neurent Medical Competitors (8)
One of Neurent Medical’s 8 competitors is Spine Wave, a Venture Capital-Backed company based in Shelton, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| Boston Scientific | Corporation | Marlborough, MA | ||||
| Amplitude Surgical | Formerly PE-Backed | Valence, France | ||||
| Tivic Health | Formerly VC-backed | Hayward, CA | ||||
| ENTvantage Dx | Venture Capital-Backed | Austin, TX |
Neurent Medical Patents
Neurent Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230133359-A1 | Systems and methods for treating chronic sinusitis | Pending | 04-Nov-2021 | ||
| EP-4426217-A2 | Systems and methods for treating chronic sinusitis | Pending | 04-Nov-2021 | ||
| US-20220104866-A1 | Systems and methods for therapeutic nasal treatment | Pending | 06-Oct-2020 | ||
| US-20220104862-A1 | Systems and methods for therapeutic nasal treatment | Pending | 06-Oct-2020 | ||
| US-20220104869-A1 | Systems and methods for therapeutic nasal treatment | Pending | 06-Oct-2020 | A61B90/98 |
Neurent Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Neurent Medical Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | Minority | ||
| EQT Life Sciences | Venture Capital | Minority | ||
| Atlantic Bridge Capital | Growth/Expansion | Minority | ||
| EIT Health | Accelerator/Incubator | Minority | ||
| Enterprise Ireland | Venture Capital | Minority |
Neurent Medical FAQs
-
When was Neurent Medical founded?
Neurent Medical was founded in 2014.
-
Where is Neurent Medical headquartered?
Neurent Medical is headquartered in Braintree, MA.
-
What is the size of Neurent Medical?
Neurent Medical has 49 total employees.
-
What industry is Neurent Medical in?
Neurent Medical’s primary industry is Therapeutic Devices.
-
Is Neurent Medical a private or public company?
Neurent Medical is a Private company.
-
What is Neurent Medical’s current revenue?
The current revenue for Neurent Medical is .
-
How much funding has Neurent Medical raised over time?
Neurent Medical has raised $46.7M.
-
Who are Neurent Medical’s investors?
MedTech Innovator, EQT Life Sciences, Atlantic Bridge Capital, EIT Health, and Enterprise Ireland are 5 of 7 investors who have invested in Neurent Medical.
-
Who are Neurent Medical’s competitors?
Spine Wave, Boston Scientific, Amplitude Surgical, Tivic Health, and ENTvantage Dx are some of the 8 competitors of Neurent Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
